These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719 [No Abstract] [Full Text] [Related]
10. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma. Dorst DN; Smeets EMM; Klein C; Frielink C; Geijs D; Trajkovic-Arsic M; Cheung PFY; Stommel MWJ; Gotthardt M; Siveke JT; Aarntzen EHJG; van Lith SAM Mol Pharm; 2023 Aug; 20(8):4319-4330. PubMed ID: 37485886 [TBL] [Abstract][Full Text] [Related]
11. Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models. Karimnia V; Rizvi I; Slack FJ; Celli JP Photochem Photobiol; 2021 Mar; 97(2):416-426. PubMed ID: 33011973 [TBL] [Abstract][Full Text] [Related]
12. Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW. Bhandari C; Fakhry J; Eroy M; Song JJ; Samkoe K; Hasan T; Hoyt K; Obaid G Front Oncol; 2022; 12():853660. PubMed ID: 35837101 [TBL] [Abstract][Full Text] [Related]
13. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma. Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602 [TBL] [Abstract][Full Text] [Related]
15. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy. Koikawa K; Kibe S; Suizu F; Sekino N; Kim N; Manz TD; Pinch BJ; Akshinthala D; Verma A; Gaglia G; Nezu Y; Ke S; Qiu C; Ohuchida K; Oda Y; Lee TH; Wegiel B; Clohessy JG; London N; Santagata S; Wulf GM; Hidalgo M; Muthuswamy SK; Nakamura M; Gray NS; Zhou XZ; Lu KP Cell; 2021 Sep; 184(18):4753-4771.e27. PubMed ID: 34388391 [TBL] [Abstract][Full Text] [Related]
16. Rapid Assessment of Bio-distribution and Antitumor Activity of the Photosensitizer Bremachlorin in a Murine PDAC Model: Detection of PDT-induced Tumor Necrosis by IRDye® 800CW Carboxylate, Using Whole-Body Fluorescent Imaging. McMorrow R; de Bruijn HS; Que I; Stuurman DC; de Ridder CMA; Doukas M; Robinson DJ; Mezzanotte L; Lowik CWGM Mol Imaging Biol; 2024 Aug; 26(4):616-627. PubMed ID: 38890241 [TBL] [Abstract][Full Text] [Related]
17. Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer. Broekgaarden M; Anbil S; Bulin AL; Obaid G; Mai Z; Baglo Y; Rizvi I; Hasan T Biomaterials; 2019 Nov; 222():119421. PubMed ID: 31494503 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D De Silva P; Bano S; Pogue BW; Wang KK; Maytin EV; Hasan T Nanophotonics; 2021 Sep; 10(12):3199-3214. PubMed ID: 37485044 [TBL] [Abstract][Full Text] [Related]
19. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027 [TBL] [Abstract][Full Text] [Related]
20. Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer. Obaid G; Eroy M; Zhao J; Bano S; Mino-Kenudson M; Hasan T J Photochem Photobiol B; 2024 Jan; 250():112811. PubMed ID: 38000171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]